Blog
Want cheaper life insurance? Have an ablation!
Healthcare reform 3 years later: An insider’s assessment
When harm in the hospital follows you home
by Olga Pierce, ProPublica
“How is it possible to move past medical harm when every single aspect of life is impacted by it – when absolutely everything a person believed about doctors, lawyers, oversight agencies, insurance companies is turned upside down and inside out?” – Robin Karr, patient harm survivor
Brazilian regulator considers accepting foreign GMP certifications
By Stewart Eisenhart, Emergo Group
Brazil’s medical device regulatory agency ANVISA may move to recognize international Good Manufacturing Practice certifications (in Portuguese) from medical device manufacturers seeking commercialization in the country.
ADMET’s eXpert 8900 series determines durability of biomaterials
List of reference countries for medical device registration published in Egypt
By Stewart Eisenhart, Emergo Group
The Central Administration for Pharmaceutical Affairs (CAPA), Egypt’s medical device market regulator, has published a list of approved reference countries that companies applying for market authorization in Egypt may leverage in their device registration efforts.
Participatory surveillance in public health: Sharing is caring
By Tom Ulrich
We humans are sharing creatures. We talk about ourselves, what we think, what we know. If we weren’t like this, cocktail parties would be really boring, and Facebook and Twitter wouldn’t exist.
It’s time for a national patient identifier
The importance of recess in our era of sequestration
You can see it in doctors’ eyes now, especially after 5 pm.
U.S. lawmakers plan hearings on medical app regulation
By Stewart Eisenhart, Emergo Group
The US House of Representatives ‘ Energy and Commerce committee will hold hearings over three days in mid March regarding the Food and Drug Administration’s approach to regulating mobile medical applications and telehealth products.